Ron Cohen, President and CEO at ACORDA THERAPEUTICS INC (ACOR), sold 38,000 shares at $33.73 ($1.3M) on 2010-03-09, disclosed to the SEC on 2010-03-10.
Open-market sale of $1.3M ACOR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.15 | 19,000 | $630K | 49.6% |
| 2 | $33.73 | 19,000 | $641K | 50.4% |
| Total | $33.44 avg | 38,000 | $1.3M | 100% |
| Filing → |
| ACOR | SELL | 2019-12-04 | $8K | — | Filing → |
| ACOR | SELL | 2018-12-06 | $75K | — | Filing → |
| ACOR | BUY | 2017-06-20 | $339K | — | Filing → |